I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 26% ± 6% | |
| astrocyte | 10 studies | 33% ± 15% | |
| oligodendrocyte | 8 studies | 26% ± 8% | |
| glutamatergic neuron | 7 studies | 41% ± 24% | |
| GABAergic neuron | 7 studies | 36% ± 21% | |
| microglial cell | 6 studies | 26% ± 7% | |
| epithelial cell | 6 studies | 29% ± 9% | |
| macrophage | 6 studies | 27% ± 6% | |
| natural killer cell | 5 studies | 20% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 17% ± 1% | |
| neuron | 5 studies | 26% ± 10% | |
| dendritic cell | 5 studies | 22% ± 11% | |
| myeloid cell | 4 studies | 22% ± 3% | |
| fibroblast | 4 studies | 19% ± 3% | |
| adipocyte | 4 studies | 19% ± 3% | |
| ciliated cell | 4 studies | 20% ± 3% | |
| lymphocyte | 4 studies | 23% ± 7% | |
| oligodendrocyte precursor cell | 4 studies | 30% ± 8% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 2% | |
| interneuron | 4 studies | 44% ± 23% | |
| classical monocyte | 3 studies | 23% ± 5% | |
| hematopoietic precursor cell | 3 studies | 21% ± 3% | |
| non-classical monocyte | 3 studies | 25% ± 9% | |
| B cell | 3 studies | 17% ± 1% | |
| alveolar macrophage | 3 studies | 22% ± 6% | |
| monocyte | 3 studies | 21% ± 3% | |
| basal cell | 3 studies | 26% ± 9% | |
| goblet cell | 3 studies | 24% ± 11% | |
| transit amplifying cell | 3 studies | 28% ± 14% | |
| mast cell | 3 studies | 20% ± 3% |
